CDC recommends RSV vaccine in late pregnancy to protect newborns

Advisors to the Centers for Disease Control and Prevention have recommended a new RSV vaccine to protect newborns by immunizing their moms late in pregnancy. (National Institute of Allergy and Infectious Diseases,/AP)

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to protect infants from respiratory syncytial virus, or RSV, by vaccinating expectant mothers

The shot – named Abryvso and made by Pfizer – is given in the third trimester to protect newborns from lower respiratory tract disease caused by RSV during their first six months of life.